The renin-angiotensin system and malignancy (Q37218569)

19 August 2017

1 reference

title

The renin-angiotensin system and malignancy (English)

1 reference

19 August 2017

Eleanor I Ager

1

1 reference

19 August 2017

Jaclyn Neo

series ordinal

2

1 reference

19 August 2017

Christopher Christophi

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

16 July 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

29

1 reference

19 August 2017

issue

9

1 reference

19 August 2017

page(s)

1675-1684

1 reference

Angiotensin receptors: a new role in cancer?

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin II receptor inhibition. A new therapeutic principle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

The role of the polymorphic genes apolipoprotein E and methylene- tetrahydrofolate reductase in the development of dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Counterregulatory actions of angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Development of angiotensin (1-7) as an agent to accelerate dermal repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Synergistic effects of co-administration of angiotensin 1–7 and Neupogen on hematopoietic recovery in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Increased angiotensin II type-2 receptor density in hyperplasia, DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Association between captopril, other antihypertensive drugs and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Perindopril: possible use in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Captopril, an angiotensin-converting enzyme inhibitor, promotes growth of immunogenic tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Tumor angiogenesis: a possible control point in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin-converting enzyme inhibition restores hepatocyte growth factor production in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

A comparative study of tumour blood flow modification in two rat tumour systems using endothelin-1 and angiotensin II: influence of tumour size on angiotensin II response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Evidence for the involvement of ET(B) receptors in ET-1-induced changes in blood flow to the rat breast tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Disparate responses of tumour vessels to angiotensin II: tumour volume-dependent effects on perfusion and oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Nonclassic endogenous novel [corrected] regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-no pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Clinical and biological significance of vascular endothelial growth factor in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Antiangiogenic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-src expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Endothelial progenitor cell differentiation and senescence in an angiotensin II-infusion rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Changes of gene expression profiles in macrophages stimulated by angiotensin II--angiotensin II induces MCP-2 through AT1-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Epithelial-mesenchymal transition and tumour invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Obstructive nephropathy: insights from genetically engineered animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Liver fibrogenesis: a new role for the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Early markers of inflammation in a high angiotensin II state--results of studies in Bartter's/Gitelman's syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin II stimulates intercellular adhesion molecule-1 via an AT1 receptor/nuclear factor-kappaB pathway in brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Tumor progression in hepatocellular carcinoma: relationship with tumor stroma and parenchymal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Epithelial-mesenchymal transition and colorectal cancer: gaining insights into tumor progression using LIM 1863 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin II and extracellular matrix homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Influence of irbesartan on expression of ILK and its relationship with epithelial-mesenchymal transition in mice with unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Histological categorisation of fibrotic cancer stroma in advanced rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, and Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN171

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGN171

1 reference

19 August 2017

1 reference